THE SHARE: Change: 0.00 SEK (-3.57%) / Price: 0.11 SEK / Apr 16, 2026, 6:00 pm (CEST)
  • Home
  • About
    • Introduction
    • Board of Directors
    • Management Team
    • Medical Advisors
    • Corporate Governance
    • Career
  • Technology
    • Physiological Targeting
    • Functional Nanoparticles
    • Publications
    • Patent
  • Portfolio
    • Pipeline
    • SpagoPix
    • Tumorad
  • Investor Relations
    • The Share
    • Analyst Coverage
    • Owners
    • Financial Reports
    • Financial Calendar
    • Equity research
    • Shareholder’s Personal Data
    • Share Issue
  • Media
    • Spago Nanomedical in media
    • Press Releases
    • Subscribe
    • Presentations
    • Events
    • Image Bank
  • Contact
    • Contact us

Regulatory

  • 30 Jun, 2022
    Spago Nanomedical announces outcome of the rights issue
  • 30 Jun, 2022
    Spago Nanomedical offentliggör utfall i företrädesemissionen
  • 9 Jun, 2022
    Spago Nanomedical offentliggör prospekt avseende företrädesemission samt uppdaterar om säkerställandegrad
  • 9 Jun, 2022
    Spago Nanomedical publishes prospectus relating to the rights issue and gives update regarding the level of undertaking
  • 1 Jun, 2022
    Spago Nanomedical carries out a rights issue of up to SEK 61.8 M
  • 1 Jun, 2022
    Spago Nanomedical genomför en företrädesemission om upp till 61,8 MSEK
  • 19 May, 2022
    Spago Nanomedical enters into an agreement on a liquidity guarantee
  • 19 May, 2022
    Spago Nanomedical ingår avtal om likviditetsgaranti
  • 18 May, 2022
    Kommuniké från årsstämma 2022 i Spago Nanomedical AB (publ)
  • 18 May, 2022
    Bulletin from the 2022 Annual General Meeting of Spago Nanomedical AB (publ)
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 26
  • Previous
  • Next
Back

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn

Member of:

Copyright © 2026 Spago Nanomedical AB. All Rights Reserved.
Design by Clavis Communications